Personal information

Emails & domains

Verified email domains

Other IDs

SciProfiles: 766364

Activities

Collapse all

Works (15)

NOTCH and PTP4A3 alterations emerge as novel predictive biomarkers and potential therapeutic targets in pleural mesothelioma

Lung Cancer
2024-12 | Journal article
DOI: 10.1016/j.lungcan.2024.108024
Contributors: Mariacarmela Santarpia; Marta Aliprandi; Calogera Claudia Spagnolo; Amir Avan; Rafael Rosell; Paolo Andrea Zucali; Elisa Giovannetti
Source: check_circle
Crossref

Prognostic Significance of PD-L1 Expression on Circulating Myeloid-Derived Suppressor Cells in NSCLC Patients Treated with Anti-PD-1/PD-L1 Checkpoint Inhibitors

International Journal of Molecular Sciences
2024-11-15 | Journal article
DOI: 10.3390/ijms252212269
Contributors: Roser Salvia; Laura G. Rico; Teresa Morán; Jolene A. Bradford; Michael D. Ward; Ana Drozdowskyj; Joan Climent-Martí; Eva M. Martínez-Cáceres; Rafael Rosell; Jordi Petriz
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Novel DNA Repair Inhibitors Targeting XPG to Enhance Cisplatin Therapy in Non-Small Cell Lung Cancer: Insights from In Silico and Cell-Based Studies

Cancers
2024-09-16 | Journal article
DOI: 10.3390/cancers16183174
Contributors: Rita Manguinhas; Patrícia A. Serra; Nuno Gil; Rafael Rosell; Nuno G. Oliveira; Rita C. Guedes
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

RE: Reply to Rio-Vilariño and colleagues’ article and misconception about YAP1 Ser 397 phosphorylation function

British Journal of Cancer
2024-06-29 | Journal article
DOI: 10.1038/s41416-024-02720-9
Contributors: Rafael Rosell
Source: check_circle
Crossref

Chemotherapy in EGFR-mutated NSCLC: optimizing combinations with TKIs and amivantamab

Nature Reviews Clinical Oncology
2024-03 | Journal article
DOI: 10.1038/s41571-023-00843-1
Contributors: Rafael Rosell; María González-Cao
Source: check_circle
Crossref

Vaccine antibodies against a synthetic epidermal growth factor variant enhance the antitumor effects of inhibitors targeting the MAPK/ERK and PI3K/Akt pathways

Translational Oncology
2024-02 | Journal article
DOI: 10.1016/j.tranon.2024.101878
Contributors: Silvia García-Roman; Mónica Garzón-Ibáñez; Jordi Bertrán-Alamillo; Núria Jordana-Ariza; Ana Giménez-Capitán; Beatriz García-Peláez; Marta Vives-Usano; Jordi Codony-Servat; Erik d'Hondt; Rafael Rosell et al.
Source: check_circle
Crossref

Unveiling Novel ERCC1–XPF Complex Inhibitors: Bridging the Gap from In Silico Exploration to Experimental Design

International Journal of Molecular Sciences
2024-01-19 | Journal article
DOI: 10.3390/ijms25021246
Contributors: Rita Manguinhas; Patrícia A. Serra; Rita B. Soares; Rafael Rosell; Nuno Gil; Nuno G. Oliveira; Rita C. Guedes
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Brief Report: circRUNX1 as Potential Biomarker for Cancer Recurrence in EGFR Mutation-Positive Surgically Resected NSCLC

JTO Clinical and Research Reports
2023-12 | Journal article
DOI: 10.1016/j.jtocrr.2023.100604
Contributors: Carlos Pedraz-Valdunciel; Masaoki Ito; Stavros Giannoukakos; Ana Giménez-Capitán; Miguel Ángel Molina-Vila; Rafael Rosell
Source: check_circle
Crossref

Liquid biopsy in detecting early non-small cell lung cancer

The Journal of Liquid Biopsy
2023-09 | Journal article
DOI: 10.1016/j.jlb.2023.100001
Contributors: Rafael Rosell; Mariacarmela Santarpia; Carlos Pedraz-Valdunciel; Giuliana Ciappina; Andrés Aguilar; Ana Giménez-Capitán; Masaoki Ito; Maria González-Cao; Miguel Angel Molina-Vila
Source: check_circle
Crossref

The Redox-Active Manganese(III) Porphyrin, MnTnBuOE-2-PyP5+, Impairs the Migration and Invasion of Non-Small Cell Lung Cancer Cells, Either Alone or Combined with Cisplatin

Cancers
2023-07-27 | Journal article
DOI: 10.3390/cancers15153814
Contributors: Rita B. Soares; Rita Manguinhas; João G. Costa; Nuno Saraiva; Nuno Gil; Rafael Rosell; Sérgio P. Camões; Ines Batinic-Haberle; Ivan Spasojevic; Matilde Castro et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Ablating lung cancer, knowing the tumor better

The Lancet Regional Health - Europe
2022-11 | Journal article
DOI: 10.1016/j.lanepe.2022.100494
Contributors: Rafael Rosell; María González-Cao
Source: check_circle
Crossref

Author Correction: KRAS inhibitors, approved

Nature Cancer
2022-04-04 | Journal article
DOI: 10.1038/s43018-022-00372-3
Contributors: Rafael Rosell; Andrés Aguilar; Carlos Pedraz; Imane Chaib
Source: check_circle
Crossref

KRAS inhibitors, approved

Nature Cancer
2021-12-21 | Journal article
DOI: 10.1038/s43018-021-00289-3
Contributors: Rafael Rosell; Andrés Aguilar; Carlos Pedraz; Imane Chaib
Source: check_circle
Crossref

Coregulation of pathways in lung cancer patients with EGFR mutation: therapeutic opportunities

British Journal of Cancer
2021-12-07 | Journal article
DOI: 10.1038/s41416-021-01519-2
Contributors: Rafael Rosell; Andrés Felipe Cardona; Oscar Arrieta; Andrés Aguilar; Masaoki Ito; Carlos Pedraz; Jordi Codony-Servat; Mariacarmela Santarpia
Source: check_circle
Crossref

Mutated circulating tumor DNA as a liquid biopsy in lung cancer detection and treatment

Molecular Oncology
2021-06 | Journal article
DOI: 10.1002/1878-0261.12983
Contributors: Martyna Filipska; Rafael Rosell
Source: check_circle
Crossref
How many people are using ORCID?